# Dr. Amira Al-Uzri, M.D. – FDA 483, Jun 18, 2026

Source: https://www.keypedia.com/records/483/dr-amira-al-uzri-md/16225a62-df17-4103-8886-56b7d694e493

> FDA 483 for Dr. Amira Al-Uzri, M.D. on June 18, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dr. Amira Al-Uzri, M.D.
- Inspection Date: 2026-06-18
- Product Type: drugs
- Office Name: Seattle District Office
- Summary: Doernbecher Childrens Hospital, Oregon Health and Science University, was inspected regarding a clinical investigation and received a Form 483. The inspection revealed significant deficiencies in maintaining accurate and contemporaneous case histories, including issues with informed consent documentation and inconsistent recordkeeping for subject data. Additionally, the firm failed to retain required investigational records and did not consistently obtain permission from both parents for pediatric subjects as required.

## Related Officers

- [Theressa B. Smith](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)
- [Gavin W. Pierce](https://www.keypedia.com/people/gavin-w-pierce/dfc6cdb8-2a63-42f4-8a19-6d394d16ee4d)

Company: https://www.keypedia.com/companies/dr-amira-al-uzri-md/31b84075-0f4e-4372-9858-b948235c0d63

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913